About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Leflunomide in Systemic Lupus Erythematosus

Leflunomide in Systemic Lupus Erythematosus

NCT00637819·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Sanofi

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Fulfill the revised ACR criteria for SLE with either evidence of active disease according to SLE Disease Activity Index (SLEDAI)

You may not be if

Patients who are pregnant or nursing women, or those with life threatening disease
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

The record

StatusCompleted

PhasePhase 2

Taking part27

StartedJan 2003

UpdatedMar 28, 2008

Conditions

Systemic Lupus Eythematosus (SLE)

Where1

Sanofi-Aventis
Hong Kong, Hong Kong